The "14th Academic Conference on Drug and Chemical Xenobiotic Metabolism of the Drug Metabolism Professional Committee of the Chinese Pharmacological Society" co-organized by the Drug Metabolism Professional Committee of the Chinese Pharmacological Society and the Drug Metabolism Professional Committee of the Shanghai Pharmacological Society, and co-organized by the Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai University of Traditional Chinese Medicine and Zunyi Medical University was successfully held at the Shanghai Royal Garden Hotel from December 6 to 8, 2024.
This conference invited well-known experts from the fields of politics, finance, industry, academia, and research across the country to conduct in-depth discussions and exchanges on a series of topics related to new DMPK issues, new understandings, new technologies, transformation of medical achievements, and drug approval regulations and policies related to new drug creation and precision medicine use under the new situation, so as to promote cooperation and development of DMPK research in academia and industry.
IPHASE Booth
At this highly anticipated industry conference, IPHASE's carefully displayed scientific research results attracted a lot of attention. From the beginning of the exhibition, an endless stream of visitors flocked to our booth. With its innovative concepts, breakthrough technologies and broad application prospects, it stood out among many exhibits, triggering heated discussions and in-depth thinking among visitors, establishing an excellent technical image for our company and laying a very solid foundation for future market expansion and cooperation and exchanges.
IPHASE Product
This conference invited well-known experts from the fields of politics, finance, industry, academia, and research across the country to conduct in-depth discussions and exchanges on a series of topics related to new DMPK issues, new understandings, new technologies, transformation of medical achievements, and drug approval regulations and policies related to new drug creation and precision medicine use under the new situation, so as to promote cooperation and development of DMPK research in academia and industry.
IPHASE Booth
At this highly anticipated industry conference, IPHASE's carefully displayed scientific research results attracted a lot of attention. From the beginning of the exhibition, an endless stream of visitors flocked to our booth. With its innovative concepts, breakthrough technologies and broad application prospects, it stood out among many exhibits, triggering heated discussions and in-depth thinking among visitors, establishing an excellent technical image for our company and laying a very solid foundation for future market expansion and cooperation and exchanges.
IPHASE Product
| Product Categories | Item NO. | Product Information |
| ADME | 01951D1.02 | IPHASE Rat(Sprague-Dawley) Liver Homogenate (pH 6.0),Female |
| 0125E1.11 | IPHASE Mouse(ICR/CD-1) Intestinal Microsomes,PMSF-free | |
| CGT research | 086E110.21 | IPHASE Mouse CD3/CD28 T Cells Activation/Expansion Kit,Beads Free |
| 086A110.22 | IPHASE Human CD3/CD28 T Cells Activation/Expansion Kit,Beads Free | |
| Genotoxicity | 0211014 | Genotoxicity Ames Test Kit-5 Bacteria Version |
| 0221014 | In-Vitro Chromosome Aberration Test Kit (with cells) | |
| Blank matrix | 0320C11.51 | IPHASE Dog(Beagle) Cerebrospinal Fluid,Male |
| 0320B11.52 | IPHASE Monkey(Cynomolgus) Cerebrospinal Fluid,Female |
Post time: 2024-12-10 11:55:05